Synergistic Glaucoma Treatment System

Publication ID: 24-11857463_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Glaucoma Treatment System,” Published Technical Disclosure No. 24-11857463_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857463_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,463.

Summary of the Inventive Concept

A novel system integrating visible and infrared ultrashort laser pulses with AI, IoT, blockchain, and nanomaterials for enhanced glaucoma treatment outcomes and personalized care.

Background and Problem Solved

The original patent disclosed methods for treating glaucoma using visible and infrared ultrashort laser pulses. However, these methods had limitations in terms of real-time monitoring, data tracking, and personalized treatment. The new inventive concept addresses these limitations by combining the original laser pulse technology with AI-powered OCT, IoT-enabled sensors, blockchain-based data storage, and nanomaterial-enhanced probes.

Detailed Description of the Inventive Concept

The synergistic glaucoma treatment system consists of four primary components: 1) a visible and infrared ultrashort laser pulse source; 2) an AI-powered OCT system for real-time monitoring of tissue removal; 3) a blockchain-based data storage module for secure tracking of treatment outcomes; and 4) IoT-enabled sensors for generating a 3D model of the patient's eye. The system operates by first generating a 3D model of the patient's eye using IoT-enabled sensors. Then, the AI-powered OCT system identifies optimal treatment sites, and the ultrashort laser pulses are directed to these sites using a robotic arm controlled by a neural network. The blockchain-based data storage module ensures secure tracking of treatment outcomes, enabling personalized treatment recommendations and predictive analytics.

Novelty and Inventive Step

The new inventive concept combines the original laser pulse technology with AI, IoT, blockchain, and nanomaterials in a novel and non-obvious way, providing enhanced glaucoma treatment outcomes and personalized care. The use of AI-powered OCT for real-time monitoring, IoT-enabled sensors for 3D modeling, and blockchain-based data storage for secure tracking of treatment outcomes are all new and inventive aspects of the system.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI algorithms for predictive analytics, various IoT devices for tracking intraocular pressure, or different nanomaterials for enhancing probe performance. Additionally, the system could be adapted for use in other ophthalmic surgical procedures, such as cataract removal or retinal detachment repair.

Potential Commercial Applications and Market

The synergistic glaucoma treatment system has significant commercial potential in the ophthalmic surgery market, particularly in the areas of glaucoma treatment and personalized medicine. The system's ability to provide enhanced treatment outcomes, real-time monitoring, and secure data tracking makes it an attractive solution for healthcare professionals and patients alike.

CPC Classifications

SectionClassGroup
A A61 A61F9/00825
A A61 A61F9/009
A A61 A61F9/0084
A A61 A61F2009/00851
A A61 A61F2009/00865
A A61 A61F2009/00868
A A61 A61F2009/00891
A A61 A61F2009/00897

Field of Art

Ophthalmic surgical technologies, specifically laser-based interventions for glaucoma treatment, requiring advanced knowledge of optical systems, laser physics, medical imaging, and minimally invasive surgical techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or ophthalmological surgical technologist with expertise in laser systems, medical imaging technologies, and advanced surgical interventions, possessing advanced degrees and practical experience in developing medical devices and surgical techniques

Obviousness Rationale

A person having ordinary skill in the art would recognize that integrating advanced digital technologies like AI, IoT, and blockchain with existing laser-based glaucoma treatment methods represents a predictable technological evolution. The source patent's foundational laser pulse technique provides a clear technical framework that a skilled practitioner would naturally seek to enhance through emerging digital monitoring and data management technologies. The PTD's variations represent logical extensions of known surgical technologies, applying standard engineering problem-solving approaches to improve precision, tracking, and personalization of medical interventions.

Obvious Combinations & Variations

Source Patent Element
Laser pulses directed through cornea to ablate trabecular meshwork
PTD Variation
AI-powered OCT system for real-time monitoring of tissue removal during laser ablation
Obviousness Reasoning
Integrating real-time imaging with laser surgical techniques is a known approach in medical technologies, representing a predictable enhancement to improve surgical precision and safety
Source Patent Element
Scanning laser pulses in adjacent regions to form surgical openings
PTD Variation
Robotic arm controlled by neural network to direct ultrashort laser pulses
Obviousness Reasoning
Automated surgical guidance systems are well-established in medical robotics, representing a natural technological progression for improving surgical accuracy and reducing human error
Source Patent Element
Transcorneal photodisruption of trabecular meshwork
PTD Variation
IoT-enabled sensors generating 3D eye model for treatment planning
Obviousness Reasoning
Advanced imaging and pre-surgical modeling are standard techniques in modern surgical planning, representing an obvious technological improvement using commercially available sensor and modeling technologies
Source Patent Element
Laser-based tissue ablation in ophthalmic surgery
PTD Variation
Blockchain-based data storage for tracking treatment outcomes
Obviousness Reasoning
Secure medical data tracking is a known requirement in modern healthcare, and blockchain represents a predictable technological solution for managing surgical intervention records
Source Patent Element
Surgical intervention for managing intraocular fluid dynamics
PTD Variation
Machine learning algorithms for identifying high-risk patients and providing personalized treatment recommendations
Obviousness Reasoning
Predictive analytics and personalized medicine are established approaches in medical technologies, representing a logical application of data analysis techniques to improve surgical outcomes
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857463 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious, as they represent predictable technological extensions combining known surgical laser techniques with emerging digital monitoring and data management technologies. The disclosed system integrates standard engineering approaches to enhance precision, tracking, and personalization of glaucoma treatment interventions, thereby rendering obvious any subsequent patent claims covering similar technological combinations.

Original Patent Information

Patent NumberUS 11,857,463
TitleMethods for the treatment of glaucoma using visible and infrared ultrashort laser pulses